Literature DB >> 8423035

Vasopressin gene expression in rats with experimental cirrhosis.

J K Kim1, S N Summer, R L Howard, R W Schrier.   

Abstract

Impaired ability to excrete a water load occurs in a substantial number of patients with advanced cirrhosis and in animals with experimental cirrhosis. The nonosmotic stimulation of arginine vasopressin release from the pituitary has been implicated as an important factor in the abnormal water excretion in patients and animals with cirrhosis. In this study, arginine vasopressin hypothalamic gene expression was studied in cirrhotic rats. Cirrhosis was induced by a combination of phenobarbital treatment in drinking water and weekly intragastric administration of carbon tetrachloride for 13 to 15 wk. Severe cirrhosis was confirmed by morphological analysis and the presence of ascites. Plasma arginine vasopressin was also significantly higher in rats with cirrhosis (control = 1.77 +/- 0.16 and cirrhotic rats = 4.14 +/- 0.62 pg/ml, n = 9, p < 0.002). Hypothalamic arginine vasopressin messenger RNA was also significantly higher in cirrhotic rats (control = 762.1 +/- 132.3 and cirrhotic rats = 1,834.2 +/- 271.9 pg/hypothalamus, n = 9, p < 0.005). Pituitary arginine vasopressin content was significantly lowered in cirrhotic rats (control = 3.69 +/- 0.98 and cirrhotic rats = 1.57 +/- 0.09 micrograms/pituitary, n = 9, p < 0.05). No difference was seen in hypothalamic arginine vasopressin content between the two groups (control = 4.64 +/- 0.34 and cirrhotic rats = 4.23 +/- 0.33 ng/hypothalamus, n = 9, NS). Oxytocin messenger RNA in the hypothalamus was also not significantly different between the two groups (control = 8.61 +/- 0.68 and cirrhotic rats = 9.33 +/- 0.65 unit of density, n = 9, NS).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423035

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

Review 1.  Water retention and aquaporins in heart failure, liver disease and pregnancy.

Authors:  R W Schrier; M A Cadnapaphornchai; M Ohara
Journal:  J R Soc Med       Date:  2001-06       Impact factor: 5.344

2.  ΔFosB in the supraoptic nucleus contributes to hyponatremia in rats with cirrhosis.

Authors:  J Thomas Cunningham; Thekkethil Prashant Nedungadi; Joseph D Walch; Eric J Nestler; Helmut B Gottlieb
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-05-23       Impact factor: 3.619

3.  Upregulation of aquaporin 2 water channel expression in pregnant rats.

Authors:  M Ohara; P Y Martin; D L Xu; J St John; T A Pattison; J K Kim; R W Schrier
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 4.  Hyponatremia in cirrhosis: pathophysiology and management.

Authors:  Savio John; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

5.  Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.

Authors:  P Y Martin; M Ohara; P Gines; D L Xu; J St John; M Niederberger; R W Schrier
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

6.  Upregulation of aquaporin-2 water channel expression in chronic heart failure rat.

Authors:  D L Xu; P Y Martin; M Ohara; J St John; T Pattison; X Meng; K Morris; J K Kim; R W Schrier
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

7.  ANG II receptor subtype 1a gene knockdown in the subfornical organ prevents increased drinking behavior in bile duct-ligated rats.

Authors:  Joseph D Walch; T Prashant Nedungadi; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-09       Impact factor: 3.619

8.  Tolvaptan regulates aquaporin-2 and fecal water in cirrhotic rats with ascites.

Authors:  Chao Chen; Ren-Pin Chen; Hai-Hua Lin; Wen-You Zhang; Xie-Lin Huang; Zhi-Ming Huang
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 9.  Paradoxes of body fluid volume regulation in health and disease. A unifying hypothesis.

Authors:  R W Schrier; M Niederberger
Journal:  West J Med       Date:  1994-10

Review 10.  Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment.

Authors:  San-E Ishikawa
Journal:  J Clin Med       Date:  2017-10-31       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.